Quick Overview: Cold Spring Harbor Laboratory scientists discovered how treatment-resistant pancreatic and lung cancers evade therapy by changing cell identity. By targeting molecular switches, KLF5 in pancreatic cancer and POU2F3/OCA-T1 in lung cancer, researchers found new ways to stop tumor growth. The Problem: Cancer cells “shapeshift” between identities to survive
Summary The FDA has granted Priority Review to a first-in-class PI3K/mTOR inhibitor for HR-positive, HER2-negative, PIK3CA wild-type advanced breast cancer. This milestone signals a potential shift in second-line treatment options globally, including for patients in Malaysia. FDA Priority Review: The U.S. FDA has accepted the NDA under Priority Review with
Summary For the first time in history, 70% of people diagnosed with cancer now survive at least five years. This global milestone reflects major advances in cancer prevention, early detection, and treatment. Global Survival Breakthrough: According to recent cancer statistics, five-year survival rates have reached 70%, signaling a major shift
summary Starting cancer treatment can feel overwhelming, but having the right information can ease the process. When you’re faced with a cancer diagnosis, it’s essential to ask your oncologist the right questions to ensure you understand your treatment options and make informed decisions. Here are some essential questions to guide
Quick Summery A recent study published in 2025 finds that cancer patients who quit smoking within six months of their diagnosis gain nearly one additional year of life. This finding challenges the misconception that quitting after cancer diagnosis is ineffective. The survival benefit applies to all cancer types and stages,
Precision Medicine, AI, and Global Collaboration in Cancer Care Take Center Stage in Berlin Dr. Christina Ng Van Tze, a respected Consultant Medical Oncologist and Medical Director at Onco Life Centre in Bangsar South, Kuala Lumpur, recently represented Malaysia at the ESMO Congress 2025 in Berlin. The global event brought
Quick Summery Cancer treatment can drastically alter a patient’s relationship with food. With side effects like loss of appetite, altered taste, and nausea, eating becomes a struggle. Programs like the Garden of Hope are helping patients rediscover the joy of eating, providing both physical and emotional healing. Food can become
Quick Read Summary This article explores how real-world evidence (RWE) is transforming prostate cancer treatment, complementing traditional randomized controlled trials (RCTs). It discusses a major observational study comparing apalutamide and enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC), showing a 23% lower mortality risk with apalutamide at 24 months. The piece
What Are Quality of Life and Health‑Related Quality of Life (HRQoL)? In cancer care, survival has long been the gold standard by which treatments are judged. But a growing movement of researchers and clinicians is pushing for another vital question: how do these treatments affect the day-to-day lives of patients?
Quick Read Summary A groundbreaking study reveals how breast cancer’s tumor microenvironment (TME) evolves during chemotherapy. Using single-cell and spatial omics, researchers mapped changes in immune cells, fibroblasts, and blood vessels highlighting how these shifts influence therapy resistance, relapse risk, and opportunities for personalized treatment. Breast tumors act as ecosystems
